Valion Bio, Inc. (VBIO)
NASDAQ: VBIO · Real-Time Price · USD
0.1209
-0.0017 (-1.39%)
At close: Aug 28, 2026, 4:00 PM EDT
0.1247
+0.0038 (3.14%)
After-hours: Aug 28, 2026, 7:49 PM EDT
Valion Bio Market Cap
Valion Bio has a market cap or net worth of $2.68 million as of August 28, 2026. Its market cap has decreased by -19.31% in one year.
Market Cap
2.68M
Enterprise Value
17.98M
1-Year Change
-19.31%
Ranking
Category
Stock Price
$0.12
ChartMarket Cap Chart
Since November 11, 2021, Valion Bio's market cap has decreased from $48.09M to $2.68M, a decrease of -94.42%. That is a compound annual growth rate of -45.21%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 28, 2026 | 2.68M | -26.75% |
| Dec 31, 2025 | 3.66M | 11.74% |
| Dec 31, 2024 | 3.28M | 24.20% |
| Dec 29, 2023 | 2.64M | -57.38% |
| Dec 30, 2022 | 6.19M | -83.57% |
| Dec 31, 2021 | 37.69M | -21.62% |
| Nov 11, 2021 | 48.09M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Galmed Pharmaceuticals | 3.55M |
| Calidi Biotherapeutics | 3.37M |
| Curis | 3.14M |
| Artelo Biosciences | 3.04M |
| Genprex | 2.96M |
| Matinas BioPharma Holdings | 2.94M |
| Clearmind Medicine | 2.69M |
| Onconetix | 2.50M |